- Home
- FET vs INBX Comparison
FET vs INBX Comparison
Compare FET & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FET
- INBX
- Stock Information
- Founded
- FET 2005
- INBX 2010
- Country
- FET United States
- INBX United States
- Employees
- FET N/A
- INBX N/A
- Industry
- FET Metal Fabrications
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- FET Industrials
- INBX Health Care
- Exchange
- FET Nasdaq
- INBX Nasdaq
- Market Cap
- FET 187.2M
- INBX 178.5M
- IPO Year
- FET 2012
- INBX 2020
- Fundamental
- Price
- FET $14.74
- INBX $13.47
- Analyst Decision
- FET
- INBX Hold
- Analyst Count
- FET 0
- INBX 1
- Target Price
- FET N/A
- INBX N/A
- AVG Volume (30 Days)
- FET 51.0K
- INBX 102.3K
- Earning Date
- FET 05-01-2025
- INBX 05-14-2025
- Dividend Yield
- FET N/A
- INBX N/A
- EPS Growth
- FET N/A
- INBX N/A
- EPS
- FET N/A
- INBX 111.58
- Revenue
- FET $807,312,000.00
- INBX $200,000.00
- Revenue This Year
- FET N/A
- INBX N/A
- Revenue Next Year
- FET $1.72
- INBX N/A
- P/E Ratio
- FET N/A
- INBX $0.12
- Revenue Growth
- FET 7.31
- INBX N/A
- 52 Week Low
- FET $12.78
- INBX $10.80
- 52 Week High
- FET $21.57
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- FET 46.36
- INBX 59.06
- Support Level
- FET $14.52
- INBX $12.25
- Resistance Level
- FET $15.09
- INBX $13.88
- Average True Range (ATR)
- FET 0.59
- INBX 0.70
- MACD
- FET 0.04
- INBX 0.20
- Stochastic Oscillator
- FET 22.44
- INBX 86.66
About FET Forum Energy Technologies Inc.
Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.